您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Mechlorethamine HCl
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Mechlorethamine HCl
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Mechlorethamine HCl图片
CAS NO:55-86-7
规格:≥98%
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议
1g电议
2g电议

产品介绍
理化性质和储存条件
Molecular Weight (MW)192.51
FormulaC5H11Cl2N.HCl
CAS No.55-86-7
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 39 mg/mL (202.6 mM)
Water: 39 mg/mL (202.6 mM)
Ethanol: 39 mg/mL (202.6 mM)
Other info

Chemical Name: 2-chloro-N-(2-chloroethyl)-N-methylethanamine hydrochloride

InChi Key: QZIQJVCYUQZDIR-UHFFFAOYSA-N

InChi Code: InChI=1S/C5H11Cl2N.ClH/c1-8(4-2-6)5-3-7;/h2-5H2,1H3;1H

SMILES Code: ClCCN(CCCl)C.[H]Cl

Synonyms

Mechlorethamine hydrochloride; chloramin; chlorethamine HCl; chlorethamine hydrochloride

实验参考方法
In Vitro

In vitro activity: Mechlorethamine is much less toxic to rat hepatocytes under nitrogen and causes much less lipid peroxidation than under aerobic conditions. Mechlorethamine markedly inhibits cell growth and leads to cell detachment associated with rearrangement of the cytoskeletal proteins in rabbit tracheal primary cultures. Mechlorethamine results in early lipid peroxidation and cellular membrane damage in rabbit tracheal primary cultures, this is correlated with a significant increase in the activities of antioxidant enzymes associated with an increase in glutathione content

In VivoMechlorethamine (1.5 mg/kg i.v.) reduces mean leukocyte count from 6,320 mm3 to 1,890 mm3 without any change in the leukocyte differential or erythrocyte and platelet counts in rabbits. Mechlorethamine (0.005 mg-0.5 mg, i.d.) causes dose-dependent skin ulcers in the mouse, and isotonic sodium thiosulfate (0.167 M) or hypertonic (0.34 M) (0.05 mL) given immediately after Mechlorethamine significantly reduces the mean HN2 ulceration area and the total time of ulceration.
Animal modelRabbits
Formulation & Dosage1.5 mg/kg i.v.
References

Toxicol In Vitro. 1997 Oct;11(5):695-702; Cancer Chemother Pharmacol. 1988;22(4):299-302.